293 related articles for article (PubMed ID: 15175980)
21. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
22. Nerve growth factor and diabetic neuropathy.
Pittenger G; Vinik A
Exp Diabesity Res; 2003; 4(4):271-85. PubMed ID: 14668049
[TBL] [Abstract][Full Text] [Related]
23. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases.
Micera A; Lambiase A; Aloe L; Bonini S; Levi-Schaffer F; Bonini S
Cytokine Growth Factor Rev; 2004 Dec; 15(6):411-7. PubMed ID: 15561599
[TBL] [Abstract][Full Text] [Related]
24. [Nerve growth factor and diabetic neuropathy].
Castellano O; Martínez-Martí L; Gómez-Fernández L
Rev Neurol; 1998 Jun; 26(154):1032-9. PubMed ID: 9658489
[TBL] [Abstract][Full Text] [Related]
25. [Neutrophins in biology and medicine].
Woszczycka-Korczyńska I; Lewin-Kowalik J; Górka D; Olakowska E
Pol Merkur Lekarski; 2006 May; 20(119):602-5. PubMed ID: 16875172
[TBL] [Abstract][Full Text] [Related]
26. Selective induction of nerve growth factor and brain-derived neurotrophic factor by LPS and allergen in dendritic cells.
Noga O; Peiser M; Altenähr M; Schmeck B; Wanner R; Dinh QT; Hanf G; Suttorp N
Clin Exp Allergy; 2008 Mar; 38(3):473-9. PubMed ID: 18167124
[TBL] [Abstract][Full Text] [Related]
27. [Cell and ex vivo gene therapy: advances in the treatment of central nervous system disorders].
Mejía-Toiber J; Castillo CG; Giordano M
Rev Neurol; 2009 Nov 1-15; 49(9):483-9. PubMed ID: 19859890
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor: basic studies and possible therapeutic applications.
Manni L; Rocco ML; Bianchi P; Soligo M; Guaragna M; Barbaro SP; Aloe L
Growth Factors; 2013 Aug; 31(4):115-22. PubMed ID: 23777359
[TBL] [Abstract][Full Text] [Related]
29. [The research advance of brain derived neurotrophic factor].
Liu Z; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Dec; 17(4):454-6, 460. PubMed ID: 11211839
[TBL] [Abstract][Full Text] [Related]
30. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
31. New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.
McDonald NQ; Lapatto R; Murray-Rust J; Gunning J; Wlodawer A; Blundell TL
Nature; 1991 Dec; 354(6352):411-4. PubMed ID: 1956407
[TBL] [Abstract][Full Text] [Related]
32. Cellular pathways leading to neuronal dysfunction and degeneration.
Kazantsev AG
Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
[TBL] [Abstract][Full Text] [Related]
33. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration.
Kalehua AN; Nagel JE; Whelchel LM; Gides JJ; Pyle RS; Smith RJ; Kusiak JW; Taub DD
Exp Cell Res; 2004 Jul; 297(1):197-211. PubMed ID: 15194436
[TBL] [Abstract][Full Text] [Related]
34. [Changes in nerve growth factor levels related to age and neurotrophic treatment in non-human primate].
Lorigados L; Pavón N; Serrano T; Robinson MA; Fernández CI; Alvarez P
Rev Neurol; 2001 Sep 1-15; 33(5):417-21. PubMed ID: 11727206
[TBL] [Abstract][Full Text] [Related]
35. Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons.
Sáez ET; Pehar M; Vargas MR; Barbeito L; Maccioni RB
J Neurosci Res; 2006 Oct; 84(5):1098-106. PubMed ID: 16862561
[TBL] [Abstract][Full Text] [Related]
36. Nature, nurture and neurology: gene-environment interactions in neurodegenerative disease. FEBS Anniversary Prize Lecture delivered on 27 June 2004 at the 29th FEBS Congress in Warsaw.
Spires TL; Hannan AJ
FEBS J; 2005 May; 272(10):2347-61. PubMed ID: 15885086
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
38. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases.
Bronfman FC; Escudero CA; Weis J; Kruttgen A
Dev Neurobiol; 2007 Aug; 67(9):1183-203. PubMed ID: 17514710
[TBL] [Abstract][Full Text] [Related]
39. In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration.
Debeir T; Marien M; Ferrario J; Rizk P; Prigent A; Colpaert F; Raisman-Vozari R
Exp Neurol; 2004 Dec; 190(2):384-95. PubMed ID: 15530877
[TBL] [Abstract][Full Text] [Related]
40. Gene transfer with DNA strand technique and peripheral nerve injuries.
Zhang F; Lineaweaver WC
J Long Term Eff Med Implants; 2002; 12(2):85-96. PubMed ID: 12463065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
